This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
ApaTech: A biomaterials success story
ABSTRACT: ApaTech is an excellent example of how innovative technology from a British university can be developed and commercialised on a global scale. Its leading product, Actifuse, competes in the crowded bone graft substitute market. Its competitors include autograft, allograft, recombinant proteins and other synthetic materials based on similar calcium phosphate technology...
The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.
Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:
- Management
- Policy
- Finance
- Law
- Regulation
- Bioethics
For more information, see the Journal of Commercial Biotechnology website